Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 11/20 | 0.42 |
| ▸ | CTSD | P07339 | 3/20 | 0.42 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.41 |
| ▸ | FNTA | P49354 | 4/20 | 0.39 |
| ▸ | FNTB | P49356 | 4/20 | 0.39 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.39 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2373402 | 0.89 | BACE1 (0.47) | BACE1CTSDDPP4DPP8DPP9 | |
| SCHEMBL31514375 | 0.89 | BACE1 (0.47) | BACE1CTSDDPP4DPP8DPP9 | |
| SCHEMBL31249620 | 0.86 | DPP4 (0.51) | BACE1CTSDDPP4DPP8DPP9 | |
| SCHEMBL30390218 | 0.85 | PDCD1LG2 (0.47) | BACE1CTSDFNTAFNTBPDCD1LG2 | |
| SCHEMBL8389736 | 0.85 | DPP4 (0.43) | BACE1CTSDDPP4DPP8DPP9 | |
| SCHEMBL8389734 | 0.85 | DPP4 (0.43) | BACE1CTSDDPP4DPP8DPP9 | |
| SCHEMBL29405948 | 0.85 | FNTA (0.44) | DPP4DPP8DPP9FNTAFNTB | |
| SCHEMBL30721621 | 0.83 | BACE1 (0.48) | BACE1CTSDDPP4DPP8DPP9 | |
| SCHEMBL30272501 | 0.83 | PDCD1LG2 (0.53) | BACE1CTSDFNTAFNTBPDCD1LG2 | |
| SCHEMBL29538092 | 0.83 | DPP4 (0.43) | BACE1CTSDDPP4DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |